Overview: Glucose Fluid TestIntroduction: The Glucose Fluid Test measures glucose in body fluids to diagnose infections or metabolic disorders, causing swelling or pain. Following 2023 IDSA guidelines, it uses an immunoassay for high sensitivity, aiding in metabolic screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in biochemistry for patients with suspected infections or metabolic issues. It is commonly used to evaluate pleural, peritoneal, or cerebrospinal fluid.
Other Names: Glucose Fluid Assay, Body Fluid Glucose Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: Fluid glucose testing began in the 1970s with infection research. Immunoassays improved in the 1990s, enhancing accuracy for diagnosing infections and metabolic disorders.
Purpose: Diagnoses infections or metabolic disorders, guides treatment, and monitors glucose levels in body fluids for patients with swelling or pain.
Test Parameters: 1. Glucose (Fluid)
Pretest Condition: Fasting for 10-12 hours required. Collect body fluid, CSF, pleural, or peritoneal fluid during clinical procedures. Report symptoms like swelling or pain, and list medications.
Specimen: 5-10 mL body fluid, pleural fluid, peritoneal fluid (sterile container), or 1-2 mL CSF (sterile container). Transport in a biohazard bag within 2 hours.
Sample Stability at Room Temperature: 2 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not frozen
Medical History: Document swelling, pain, or history of infections or metabolic disorders. Include current medications, especially antibiotics or antidiabetics.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for treatment or further fluid analysis.
Procedural Considerations: Uses an immunoassay to measure glucose levels in body fluids. Results are available in 1-2 days, enabling rapid clinical decisions. Performed in laboratories, often paired with fluid cell counts or cultures.
Factors Affecting Result Accuracy: Contamination, improper collection, or hemolysis can affect results. Systemic glucose levels may influence fluid results.
Clinical Significance: Low glucose levels in fluids suggest infections (e.g., bacterial meningitis) or metabolic disorders, prompting treatment. Normal levels may require further testing.
Specialist Consultation: Consult an infectious disease specialist or neurologist for result interpretation, depending on fluid type.
Additional Supporting Tests: Fluid cell count, culture, protein levels, or imaging (e.g., CT) to confirm infections or metabolic disorders.
Test Limitations: Non-specific glucose changes may occur in non-infectious conditions. Results require clinical correlation and additional testing.
References: IDSA Fluid Analysis Guidelines, 2023; Clinical Infectious Diseases, Tunkel AR, 2022.
